🔎 Trials Near Me

Akèy › Ateroskleroz › Washington

Etid klinik pou Ateroskleroz nan Washington, DC

9 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 7 a 100 · Tout sèks · Mizajou Oct 5, 2026 · NCT03581318

New Heart Imaging Techniques to Evaluate Possible Heart Disease

Ap rekriteVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01399385

Causes and Natural History of Dyslipidemias

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT00353782

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Hope Center, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 1 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01143454

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Ap rekriteFaz 3
  • Metropolitan Cardiovascular Consultants, Beltsville · 12 mi lwen
  • Flourish Research - Bowie, Bowie · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Lanham · 11 mi lwen
  • Research Site, Beltsville · 12 mi lwen
  • Research Site, Bowie · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Ap rekriteFaz 3
  • Flourish Research Bowie, Bowie · 17 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

Ap rekriteFaz 3
  • Capitol Cardiology Associates, Lanham · 11 mi lwen
  • Metropolitan Cardiovascular Consultants Llc, Beltsville · 12 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT06875973

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 10 a 90 · Tout sèks · Mizajou Mar 23, 2026 · NCT06676046

Etid Ateroskleroz nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.